Ars Pharmaceuticals, Inc.

This study compares a new nasal spray (neffy) to the standard injected adrenalin for treating severe allergic reactions. About 600 people aged 4 and older who have an allergic reaction during a food challenge or allergy shot will receive one of the two treatments. Researchers wil…

This study tests an experimental drug called ARS-2 for people with chronic spontaneous urticaria (long-term hives). Participants take a single dose of ARS-2 or a placebo during a flare-up to see if it reduces itching and hives. The trial involves 42 adults aged 18-65 who have mod…